What are the target random blood glucose levels before and after meals during hospital admission?

Target Blood Glucose Levels During Hospital Admission

For hospitalized patients, target premeal glucose <140 mg/dL (7.8 mmol/L) and random/postmeal glucose <180 mg/dL (10.0 mmol/L) for the majority of non-critically ill patients. 1, 2

Specific Targets by Clinical Setting

Non-Critically Ill Patients (General Medical/Surgical Wards)

Premeal targets:

• <140 mg/dL (7.8 mmol/L) - this is the primary target before breakfast, lunch, and dinner 1, 2, 3

Random/Postmeal targets:

• <180 mg/dL (10.0 mmol/L) - measured at any time between meals or after eating 1, 2, 3

Broader acceptable range:

• The 2023 ADA Standards recommend an overall target range of 100-180 mg/dL (5.6-10.0 mmol/L) for noncritically ill patients, which encompasses both fasting and postprandial values 1

Critically Ill Patients (ICU Setting)

Target range:

• 140-180 mg/dL (7.8-10.0 mmol/L) once insulin therapy is initiated 1, 3
• Initiate insulin therapy when glucose persistently exceeds 180 mg/dL (10.0 mmol/L) 1, 4

More stringent targets (110-140 mg/dL) may be considered for:

• Post-cardiac surgery patients
• Post-vascular surgery patients
• Only if achievable without significant hypoglycemia 1, 3

Safety Thresholds and Modifications

Hypoglycemia prevention:

• Reassess insulin regimen when glucose falls below 100 mg/dL (5.6 mmol/L) 2, 3
• Modify treatment when glucose <70 mg/dL (3.9 mmol/L) 2, 3
• Fasting glucose <100 mg/dL predicts hypoglycemia within 24 hours 1

Higher targets acceptable for:

• Terminally ill patients with limited life expectancy: glucose <200-250 mg/dL (11.1-13.9 mmol/L) may be reasonable 1, 2
• Patients at high risk for hypoglycemia 2

Monitoring Schedule

For patients eating meals:

• Check glucose before each meal and at bedtime 2, 1, 4

For patients NPO (nothing by mouth) or on continuous tube feeding:

• Check glucose every 4-6 hours 2, 1, 4

Key Clinical Considerations

The most recent 2023 and 2025 ADA guidelines 1, 4 represent the highest quality evidence and maintain consistency with the 2012 Endocrine Society guideline 2, which provides the most detailed breakdown of premeal versus random targets. The premeal <140 mg/dL and random <180 mg/dL targets have remained stable across multiple guideline iterations, reflecting strong consensus based on balancing hyperglycemia risks against hypoglycemia prevention.

Critical pitfall to avoid: Do not target glucose <110 mg/dL in most hospitalized patients, as intensive glycemic control (attempting near-euglycemia) increases mortality and hypoglycemia rates 10-15 fold compared to moderate targets, as demonstrated by the landmark NICE-SUGAR trial 1.

The distinction between premeal and random/postmeal targets is clinically important because it guides timing of glucose checks and insulin administration, with premeal values directing prandial insulin doses and random values triggering reassessment of the overall regimen.